Parallax Volatility Advisers’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $814K | Buy |
+1,623
| New | +$779K | ﹤0.01% | 1011 |
|
|
2026
Q1 | – | Sell |
-1,116
| Closed | -$647K | – | 1836 |
|
|
2025
Q4 | $647K | Buy |
+1,116
| New | +$631K | ﹤0.01% | 1188 |
|
|
2025
Q2 | – | Sell |
-5,803
| Closed | -$2.43M | – | 1813 |
|
|
2025
Q1 | $2.89M | Buy |
5,803
+1,230
| +27% | +$666K | 0.01% | 769 |
|
|
2024
Q4 | $2.38M | Buy |
+4,573
| New | +$2.51M | ﹤0.01% | 1085 |
|
|
2021
Q4 | – | Sell |
-61,126
| Closed | -$38.2M | – | 2335 |
|
|
2021
Q3 | $34.9M | Buy |
61,126
+11,945
| +24% | +$6.56M | 0.03% | 319 |
|
|
2021
Q2 | $24.8M | Buy |
49,181
+35,544
| +261% | +$16.8M | 0.03% | 326 |
|
|
2021
Q1 | $6.22M | Sell |
13,637
-7,708
| -36% | -$3.68M | 0.01% | 468 |
|
|
2020
Q4 | $9.94M | Sell |
21,345
-2,046
| -9% | -$959K | 0.01% | 727 |
|
|
2020
Q3 | $10.3M | Sell |
23,391
-45,296
| -66% | -$18.7M | 0.01% | 983 |
|
|
2020
Q2 | $24.9M | Buy |
68,687
+44,265
| +181% | +$14.8M | 0.03% | 448 |
|
|
2020
Q1 | $6.93M | Sell |
24,422
-30,389
| -55% | -$9.58M | 0.01% | 744 |
|
|
2019
Q4 | $17.8M | Buy |
+54,811
| New | +$16.6M | 0.02% | 457 |
|
|
2019
Q3 | – | Sell |
-355
| Closed | -$102K | – | 3454 |
|
|
2019
Q2 | $104K | Sell |
355
-1,223
| -78% | -$337K | ﹤0.01% | 1850 |
|
|
2019
Q1 | $432K | Sell |
1,578
-22,329
| -93% | -$5.56M | ﹤0.01% | 1593 |
|
|
2018
Q4 | $5.35M | Buy |
+23,907
| New | +$5.61M | 0.01% | 689 |
|
|
2018
Q1 | – | Sell |
-13,872
| Closed | -$2.91M | – | 4169 |
|
|
2017
Q4 | $2.63M | Buy |
+13,872
| New | +$2.66M | ﹤0.01% | 826 |
|
|
2017
Q3 | – | Sell |
-4,331
| Closed | -$784K | – | 3260 |
|
|
2017
Q2 | $756K | Buy |
4,331
+1,204
| +39% | +$202K | ﹤0.01% | 1116 |
|
|
2017
Q1 | $480K | Buy |
+3,127
| New | +$478K | ﹤0.01% | 1508 |
|
|
2016
Q3 | – | Sell |
-6,430
| Closed | -$991K | – | 3920 |
|
|
2016
Q2 | $950K | Buy |
+6,430
| New | +$949K | ﹤0.01% | 1208 |
|
|
2016
Q1 | – | Sell |
-706
| Closed | -$94.6K | – | 3667 |
|
|
2015
Q4 | $100K | Buy |
706
+611
| +643% | +$81.5K | ﹤0.01% | 2127 |
|
|
2015
Q3 | $12K | Buy |
+95
| New | +$12.4K | ﹤0.01% | 2540 |
|
|
2015
Q2 | – | Sell |
-862
| Closed | -$112K | – | 4903 |
|
|
2015
Q1 | $116K | Sell |
862
-6,903
| -89% | -$890K | ﹤0.01% | 2419 |
|
|
2014
Q4 | $973K | Buy |
7,765
+5,767
| +289% | +$701K | ﹤0.01% | 1533 |
|
|
2014
Q3 | $243K | Sell |
1,998
-2,392
| -54% | -$291K | ﹤0.01% | 2338 |
|
|
2014
Q2 | $518K | Sell |
4,390
-7,548
| -63% | -$888K | ﹤0.01% | 1367 |
|
|
2014
Q1 | $1.44M | Sell |
11,938
-11,326
| -49% | -$1.35M | 0.01% | 671 |
|
|
2013
Q4 | $2.59M | Buy |
23,264
+22,202
| +2,091% | +$2.21M | 0.01% | 598 |
|
|
2013
Q3 | $98K | Sell |
1,062
-753
| -41% | -$68.1K | ﹤0.01% | 1453 |
|
|
2013
Q2 | $154K | Buy |
+1,815
| New | +$151K | ﹤0.01% | 1113 |
|
Other funds holding TMO
Parallax Volatility Advisers's TMO Position: Q2 2026 in Review
Parallax Volatility Advisers opened a new position in Thermo Fisher Scientific (TMO) in Q2 2026: 1,623 shares worth $814K. The stake represents ﹤0.01% of the portfolio and ranks #1011 among its holdings. This is a return to the name: Parallax Volatility Advisers previously reported a position in TMO as recently as Q4 2025.
Parallax Volatility Advisers first reported a position in TMO in Q2 2013 and has held it in 29 quarters since. The position peaked at $34.9M in Q3 2021. 2,602 funds tracked by Wall St. Rank hold TMO as of Q2 2026.
- Parallax Volatility Advisers held 1,623 shares of Thermo Fisher Scientific worth $814K as of Q2 2026.
- Thermo Fisher Scientific was a new Parallax Volatility Advisers position in Q2 2026.
- Thermo Fisher Scientific made up ﹤0.01% of Parallax Volatility Advisers's portfolio in Q2 2026, its #1011 holding.
- Parallax Volatility Advisers first reported a position in Thermo Fisher Scientific in Q2 2013 and has held it in 29 quarters since.
- Parallax Volatility Advisers's Thermo Fisher Scientific position peaked at $34.9M in Q3 2021.
- 2,602 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.
Based on Parallax Volatility Advisers's 13F filing for Q2 2026, filed 14 Aug 2026.